{"id":6556,"date":"2006-04-10T14:55:00","date_gmt":"2006-04-10T14:55:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=6556"},"modified":"2022-01-25T14:36:36","modified_gmt":"2022-01-25T14:36:36","slug":"case-report-combination-therapy-withgranulocyte-apheresis-and-infliximab-for-refractory-crohns-disease","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/es\/professional\/scientific-corner\/case-report-combination-therapy-withgranulocyte-apheresis-and-infliximab-for-refractory-crohns-disease\/","title":{"rendered":"Case Report: Combination Therapy With Granulocyte Apheresis and Infliximab for Refractory Crohn\u2019s Disease"},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>P. Gonzalez Carro, F. Perez Roldan, O. Roncero Garc\u0131a Escribano,R. Lafuente, M.L. Legaz Huidobro, and A. Amigo Echenagus\u0131a<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Journal of Clinical Apheresis 21: 249\u2013251 (2006) <\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>To our knowledge, no cases of combined therapy with infliximab and granulocyte apheresis have been previously reported. Our results suggest that this combined therapy is a possible alternative to treat CD patients in the event of loss of response to  infliximab.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jca.20093\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jca.20093<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>P. Gonzalez Carro, F. Perez Roldan, O. Roncero Garc\u0131a Escribano,R. Lafuente, M.L. Legaz Huidobro, and A. Amigo Echenagus\u0131a Journal of Clinical Apheresis 21: 249\u2013251 (2006) To our knowledge, no cases of combined therapy with infliximab and granulocyte apheresis have been previously reported. Our results suggest that this combined therapy is a possible alternative to treat [&hellip;]<\/p>\n","protected":false},"template":"","scientific_tags":[276,303,159,424,109,434,461],"class_list":["post-6556","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-cases","scientific_tags-combination","scientific_tags-crohns-disease","scientific_tags-gma","scientific_tags-infliximab","scientific_tags-loss-of-response","scientific_tags-refractory"],"acf":{"sc_authors":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Case Report: Combination Therapy With Granulocyte Apheresis and Infliximab for Refractory Crohn\u2019s Disease - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/case-report-combination-therapy-withgranulocyte-apheresis-and-infliximab-for-refractory-crohns-disease\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Case Report: Combination Therapy With Granulocyte Apheresis and Infliximab for Refractory Crohn\u2019s Disease - Adacyte\" \/>\n<meta property=\"og:description\" content=\"P. Gonzalez Carro, F. Perez Roldan, O. Roncero Garc\u0131a Escribano,R. Lafuente, M.L. Legaz Huidobro, and A. Amigo Echenagus\u0131a Journal of Clinical Apheresis 21: 249\u2013251 (2006) To our knowledge, no cases of combined therapy with infliximab and granulocyte apheresis have been previously reported. Our results suggest that this combined therapy is a possible alternative to treat [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/case-report-combination-therapy-withgranulocyte-apheresis-and-infliximab-for-refractory-crohns-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2022-01-25T14:36:36+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/case-report-combination-therapy-withgranulocyte-apheresis-and-infliximab-for-refractory-crohns-disease\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/case-report-combination-therapy-withgranulocyte-apheresis-and-infliximab-for-refractory-crohns-disease\/\",\"name\":\"Case Report: Combination Therapy With Granulocyte Apheresis and Infliximab for Refractory Crohn\u2019s Disease - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2006-04-10T14:55:00+00:00\",\"dateModified\":\"2022-01-25T14:36:36+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/case-report-combination-therapy-withgranulocyte-apheresis-and-infliximab-for-refractory-crohns-disease\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Case Report: Combination Therapy With Granulocyte Apheresis and Infliximab for Refractory Crohn\u2019s Disease - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/case-report-combination-therapy-withgranulocyte-apheresis-and-infliximab-for-refractory-crohns-disease\/","og_locale":"es_ES","og_type":"article","og_title":"Case Report: Combination Therapy With Granulocyte Apheresis and Infliximab for Refractory Crohn\u2019s Disease - Adacyte","og_description":"P. Gonzalez Carro, F. Perez Roldan, O. Roncero Garc\u0131a Escribano,R. Lafuente, M.L. Legaz Huidobro, and A. Amigo Echenagus\u0131a Journal of Clinical Apheresis 21: 249\u2013251 (2006) To our knowledge, no cases of combined therapy with infliximab and granulocyte apheresis have been previously reported. Our results suggest that this combined therapy is a possible alternative to treat [&hellip;]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/case-report-combination-therapy-withgranulocyte-apheresis-and-infliximab-for-refractory-crohns-disease\/","og_site_name":"Adacyte","article_modified_time":"2022-01-25T14:36:36+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/case-report-combination-therapy-withgranulocyte-apheresis-and-infliximab-for-refractory-crohns-disease\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/case-report-combination-therapy-withgranulocyte-apheresis-and-infliximab-for-refractory-crohns-disease\/","name":"Case Report: Combination Therapy With Granulocyte Apheresis and Infliximab for Refractory Crohn\u2019s Disease - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2006-04-10T14:55:00+00:00","dateModified":"2022-01-25T14:36:36+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/case-report-combination-therapy-withgranulocyte-apheresis-and-infliximab-for-refractory-crohns-disease\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner\/6556","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/media?parent=6556"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific_tags?post=6556"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}